Clinical Implementation of suPARnostic® TurbiLatex in routine use at León Hospital in Spain

Tue Apr 14 2020

suPARnostic® TurbiLatex will now aid clinical decision-making in the Emergency Department at Complejo Asistencial Universitario de León (León Hospital) in Spain, marking the first implementation of suPARnostic® in Spanish hospitals.

León Hospital, a 1056-bed university facility in Spain’s Castilla y León region, will utilize suPAR as a routine marker for triaging acute medical patients, aiming to

León Hospital in Spain

reduce unnecessary admissions. Additionally, suPARnostic® will assist in triaging patients admitted with suspected COVID-19 infection.

Jakob Knudsen, CEO of ViroGates, expresses anticipation for a long-term partnership with León Hospital, emphasizing the role of suPARnostic® in supporting triage procedures in the Emergency Department. Knudsen further notes the significance of aiding León Hospital during the COVID-19 outbreak to enhance their capacity in managing the substantial patient influx and optimizing resource allocation.

1000+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 4 products:

Quick Triage

A Point of Care Solution

TurbiLatex

For Automated Systems

ELISA Assay

Clinical and Research

suPARnostic POC+

POC+

Point-of-care finger prick

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates